DarioHealth (DRIO) Invested Capital (2012 - 2026)

DarioHealth has reported Invested Capital for 15 years, with the latest figure at $62.4 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 25.73% year-over-year to $62.4 million; the trailing twelve-month figure through Mar 2026 stood at $62.4 million (down 25.73% YoY), and the FY2025 full-year result was $67.9 million, down 12.32% from the prior year.
• Invested Capital for Q1 2026 stood at $62.4 million, down from $67.9 million in the prior quarter.
• The five-year high for Invested Capital was $114.6 million in Q1 2022, with the low at $62.1 million in Q4 2023.
• Historically, Invested Capital has averaged $78.7 million across 5 years, with a median of $77.5 million in 2024.
• Annual changes were most pronounced in 2023 — Invested Capital plunged 30.09% — and 2024, when it grew 24.75%.
• DarioHealth's Invested Capital stood at $88.8 million in 2022, then slumped by 30.09% to $62.1 million in 2023, then gained by 24.75% to $77.5 million in 2024, then slipped by 12.32% to $67.9 million in 2025, then dropped by 8.16% to $62.4 million in 2026.
• The last three Invested Capital figures came in at $62.4 million (Q1 2026), $67.9 million (Q4 2025), and $74.9 million (Q3 2025), per Business Quant data.